Edition:
United States

Bioblast Pharma Ltd (ORPN.OQ)

ORPN.OQ on NASDAQ Stock Exchange Capital Market

1.28USD
18 Sep 2018
Change (% chg)

-- (--)
Prev Close
$1.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
21,172
52-wk High
$5.99
52-wk Low
$1.03

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.170
Sep '17 0.00 -0.320
Jun '17 0.00 -0.496
Mar '17 0.00 -0.815
FY 2016 Dec '16 0.00 -0.939
Sep '16 0.00 -1.424
Jun '16 0.00 -1.124
Mar '16 0.00 -1.588
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 103.50 32.14
P/E High - Last 5 Yrs. -- 275.43 47.40
P/E Low - Last 5 Yrs. -- 97.43 24.78
Beta 0.46 0.62 0.87
Price to Sales (TTM) -- 109.71 6.23
Price to Book (MRQ) 1.35 12.03 3.80
Price to Tangible Book (MRQ) 1.35 18.41 5.78
Price to Cash Flow (TTM) -- 59.58 22.50
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.73
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.55 -5.60
Payout Ratio(TTM) -- 5.86 46.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 174.85 8.41
Sales (TTM) vs TTM 1 Yr. Ago -- 91.86 6.69
Sales - 5 Yr. Growth Rate -- 24.26 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago 81.87 272.94 25.39
EPS (TTM) vs TTM 1 Yr. Ago 64.49 -- --
EPS - 5 Yr. Growth Rate -- 23.39 7.57
Capital Spending - 5 Yr. Growth Rate -- 38.46 8.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.61 2.18
Current Ratio (MRQ) 7.87 5.48 2.95
LT Debt to Equity (MRQ) 0.00 14.97 11.33
Total Debt to Equity (MRQ) 0.00 18.40 14.17
Interest Coverage (TTM) -- -204.17 34.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.80 54.77
Gross Margin - 5 Yr. Avg. -- 52.46 53.26
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -175.51 15.90
Operating Margin (TTM) -- -608.67 3.68
Operating Margin - 5 Yr. Avg. -- -189.07 11.01
Pre-Tax Margin (TTM) -- -605.68 3.97
Pre-Tax Margin - 5 Yr. Avg. -- -191.53 11.18
Net Profit Margin (TTM) -- -601.23 0.71
Net Profit Margin - 5 Yr. Avg. -- -189.32 7.52
Effective Tax Rate (TTM) -- 11.41 20.36
Effective Tax Rate - 5 Yr. Avg. -- 18.93 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 5,162,908 710,435,462
Net Income/Employee (TTM) -- -6,026,407 81,903,466
Receivable Turnover (TTM) -- 5.43 5.02
Inventory Turnover (TTM) -- 2.04 3.62
Asset Turnover (TTM) 0.00 0.37 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -83.43 0.74 9.68
Return on Assets - 5 Yr. Avg. -68.63 2.54 10.88
Return on Investment (TTM) -100.24 1.52 12.66
Return on Investment - 5 Yr. Avg. -76.90 2.08 14.01
Return on Equity (TTM) -100.24 0.25 14.84
Return on Equity - 5 Yr. Avg. -77.03 -1.25 15.40
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 64.38 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Bioblast Pharma Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 18.22%
# of Holders: 4
Total Shares Held: 608,986
3 Mo. Net Change: -15,205
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 1
# Reduced Positions: 2
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.